Literature DB >> 10348371

Inhibitory effects of indomethacin on interleukin-1 and nitric oxide production in rat microglia in vitro.

Z Y Du1, X Y Li.   

Abstract

Indomethacin, as a nonsteroidal antiinflammatory drug, is reported to be effective in some degree in the prevention and treatment of Alzheimer's disease (AD). Effects of indomethacin on proinflammatory cytokines interleukin-1 (IL-1), tumor necrosis factor alpha and nitric oxide (NO) on rat microglia in vitro were investigated. The biological activities of IL-1 were assayed by thymocyte proliferation assay and the activities of TNG-alpha, by L929 cytotoxicity assay. NO concentration was represented by nitrite and determined by Griess reaction. Indomethacin inhibited IL-1 and NO production by rat microglia stimulated at the concentration of 0.1-10 micromol/l. However, it did not show any inhibitory effect on TNF-alpha production by resting and LPS-stimulated rat microglia. The results suggest that the mechanism by which indomethacin might be beneficial in treatment of AD might be due to the inhibition IL-1 and NO production from microglia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10348371     DOI: 10.1016/s0192-0561(98)00084-8

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  14 in total

1.  In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.

Authors:  Seoyeon Bok; Taejun Wang; Chan-Ju Lee; Seong-Uk Jeon; Young-Eun Kim; Jeongwoo Kim; Beom-Ju Hong; Calvin Jinse Yoon; Sungjee Kim; Seung-Hoon Lee; Hak Jae Kim; Il Han Kim; Ki Hean Kim; G-One Ahn
Journal:  Biomed Opt Express       Date:  2015-08-07       Impact factor: 3.732

2.  A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches.

Authors:  Oliver Summ; Anna P Andreou; Simon Akerman; Peter J Goadsby
Journal:  J Headache Pain       Date:  2010-10-27       Impact factor: 7.277

3.  Urinary nitrite excretion and urinary variables in patients with primary nocturnal frequency of micturition: effects of indomethacin suppositories.

Authors:  Noori S Al-Waili; Thia N Al-Waili; Ali N Al-Waili; Khelod Y Saloom
Journal:  World J Urol       Date:  2005-09-27       Impact factor: 4.226

Review 4.  Role of the immune system in the pathogenesis, prevention and treatment of Alzheimer's disease.

Authors:  Imrich Blasko; Beatrix Grubeck-Loebenstein
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 5.  Mechanisms of non-opioid analgesics beyond cyclooxygenase enzyme inhibition.

Authors:  May Hamza; Raymond A Dionne
Journal:  Curr Mol Pharmacol       Date:  2009-01       Impact factor: 3.339

Review 6.  Mechanism of action of indomethacin in indomethacin-responsive headaches.

Authors:  Oliver Summ; Stefan Evers
Journal:  Curr Pain Headache Rep       Date:  2013-04

Review 7.  Indomethacin-responsive headache syndromes.

Authors:  David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2004-02

Review 8.  Indomethacin for the treatment of Alzheimer's disease patients.

Authors:  N Tabet; H Feldman
Journal:  Cochrane Database Syst Rev       Date:  2002

9.  The role of beta-amyloid protein in synaptic function: implications for Alzheimer's disease therapy.

Authors:  F Peña; Ai Gutiérrez-Lerma; R Quiroz-Baez; C Arias
Journal:  Curr Neuropharmacol       Date:  2006-04       Impact factor: 7.363

10.  Reduction of nuclear peroxisome proliferator-activated receptor gamma expression in methamphetamine-induced neurotoxicity and neuroprotective effects of ibuprofen.

Authors:  Takeshi Tsuji; Masato Asanuma; Ikuko Miyazaki; Ko Miyoshi; Norio Ogawa
Journal:  Neurochem Res       Date:  2008-10-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.